Anna Darabi

Medicin och livsvetenskap

1. Glioma 100%
2. Immunotherapy 65%
3. Brain Neoplasms 52%
4. Neoplasms 49%
5. Medulloblastoma 46%
6. Immunization 42%
7. Interferon-gamma 29%
8. T-Lymphocytes 28%
9. Glioblastoma 23%
10. Interleukin-7 20%
11. Granulocyte-Macrophage Colony-Stimulating Factor 18%
12. Aluminum 18%
13. tapasin 17%
14. Nitric Oxide Synthase Type II 16%
15. Temozolomide 15%
16. Cyclooxygenase 2 14%
17. Leukocytes 13%
18. 4-chloro-3-(2,4-dihydroxyphenylazo)-2-hydroxybenzene-1-sulfonic acid 13%
19. Interleukin-10 11%
20. Macrophages 10%
21. 2-mercaptoethylguanidine 10%
22. Theoretical Models 9%
23. Mesenchymal Stem Cells 9%
24. Major Histocompatibility Complex 9%
25. Cytomegalovirus 9%
26. Pediatrics 9%
27. Therapeutics 8%
28. Bone Marrow 8%
29. Dinoprostone 8%
30. Preclinical Drug Evaluations 8%
31. Cytophagocytosis 7%
32. In Vitro Techniques 7%
33. Convection 7%
34. Tumor Necrosis Factor-alpha 7%
35. Paracrine Communication 7%
36. Receptors, Tumor Necrosis Factor, Type II 7%
37. Histocompatibility Antigens Class I 7%
38. Proteins 7%
39. Circular RNAs 7%
40. Animals 7%
41. Transforming Growth Factor beta1 7%
42. Regulatory T-Lymphocytes 6%
43. Stem Cells 6%
44. Th1 Cells 6%
45. Staining and Labeling 6%
46. Peptides 6%
47. Antigen Presentation 6%
48. Hedgehog Proteins 6%
49. Catenins 6%
50. Nestin 6%